These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 33080582)

  • 1. Nitric oxide's physiologic effects and potential as a therapeutic agent against COVID-19.
    Ricciardolo FLM; Bertolini F; Carriero V; Högman M
    J Breath Res; 2020 Dec; 15(1):014001. PubMed ID: 33080582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide as a double-edged sword in pulmonary viral infections: Mechanistic insights and potential therapeutic implications.
    Masood M; Singh P; Hariss D; Khan F; Yameen D; Siraj S; Islam A; Dohare R; Mahfuzul Haque M
    Gene; 2024 Mar; 899():148148. PubMed ID: 38191100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential for personalised application of inhaled nitric oxide in COVID-19 pneumonia.
    Garfield B; McFadyen C; Briar C; Bleakley C; Vlachou A; Baldwin M; Lees N; Price S; Ledot S; McCabe C; Wort SJ; Patel BV; Price LC
    Br J Anaesth; 2021 Feb; 126(2):e72-e75. PubMed ID: 33288208
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeting the SphK-S1P-SIPR Pathway as a Potential Therapeutic Approach for COVID-19.
    McGowan EM; Haddadi N; Nassif NT; Lin Y
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 33003377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saying no to SARS-CoV-2: the potential of nitric oxide in the treatment of COVID-19 pneumonia.
    Zhang H; Zhang C; Hua W; Chen J
    Med Gas Res; 2024; 14(2):39-47. PubMed ID: 37929506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could nasal nitric oxide help to mitigate the severity of COVID-19?
    Martel J; Ko YF; Young JD; Ojcius DM
    Microbes Infect; 2020; 22(4-5):168-171. PubMed ID: 32387333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of SARS-Cov-2 infection on eNOS and iNOS activity: Consequences for the respiratory and vascular systems.
    Guimarães LMF; Rossini CVT; Lameu C
    Nitric Oxide; 2021 Jun; 111-112():64-71. PubMed ID: 33831567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
    Maury A; Lyoubi A; Peiffer-Smadja N; de Broucker T; Meppiel E
    Rev Neurol (Paris); 2021; 177(1-2):51-64. PubMed ID: 33446327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic Multi-omic Analysis of Responses to SARS-CoV-2 Infection in a Model of Severe COVID-19.
    Cantwell AM; Singh H; Platt M; Yu Y; Lin YH; Ikeno Y; Hubbard G; Xiang Y; Gonzalez-Juarbe N; Dube PH
    J Virol; 2021 Sep; 95(20):e0101021. PubMed ID: 34319784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurological consequences of COVID-19: what have we learned and where do we go from here?
    Jarrahi A; Ahluwalia M; Khodadadi H; da Silva Lopes Salles E; Kolhe R; Hess DC; Vale F; Kumar M; Baban B; Vaibhav K; Dhandapani KM
    J Neuroinflammation; 2020 Sep; 17(1):286. PubMed ID: 32998763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct Activation of Endothelial Cells by SARS-CoV-2 Nucleocapsid Protein Is Blocked by Simvastatin.
    Qian Y; Lei T; Patel PS; Lee CH; Monaghan-Nichols P; Xin HB; Qiu J; Fu M
    J Virol; 2021 Nov; 95(23):e0139621. PubMed ID: 34549987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silent Hypoxemia in Patients with COVID-19 Pneumonia: A Review.
    Guo L; Jin Z; Gan TJ; Wang E
    Med Sci Monit; 2021 Oct; 27():e930776. PubMed ID: 34635632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human and novel coronavirus infections in children: a review.
    Rajapakse N; Dixit D
    Paediatr Int Child Health; 2021 Feb; 41(1):36-55. PubMed ID: 32584199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computing the Effects of SARS-CoV-2 on Respiration Regulatory Mechanisms in COVID-19.
    Baig AM
    ACS Chem Neurosci; 2020 Aug; 11(16):2416-2421. PubMed ID: 32600045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ZMPSTE24 Regulates SARS-CoV-2 Spike Protein-enhanced Expression of Endothelial PAI-1.
    Han M; Pandey D
    Am J Respir Cell Mol Biol; 2021 Sep; 65(3):300-308. PubMed ID: 34003736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The importance of vitamin d metabolism as a potential prophylactic, immunoregulatory and neuroprotective treatment for COVID-19.
    Xu Y; Baylink DJ; Chen CS; Reeves ME; Xiao J; Lacy C; Lau E; Cao H
    J Transl Med; 2020 Aug; 18(1):322. PubMed ID: 32847594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ischemic stroke in COVID-19-positive patients: an overview of SARS-CoV-2 and thrombotic mechanisms for the neurointerventionalist.
    Zakeri A; Jadhav AP; Sullenger BA; Nimjee SM
    J Neurointerv Surg; 2021 Mar; 13(3):202-206. PubMed ID: 33298508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nitric Oxide: The Missing Factor in COVID-19 Severity?
    Nikolaidis A; Kramer R; Ostojic S
    Med Sci (Basel); 2021 Dec; 10(1):. PubMed ID: 35076566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 Anosmia: High Prevalence, Plural Neuropathogenic Mechanisms, and Scarce Neurotropism of SARS-CoV-2?
    Liang F; Wang Y
    Viruses; 2021 Nov; 13(11):. PubMed ID: 34835030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.